Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

BACKGROUND: Elderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF‐TIMI 48 trial, we evaluate clinical outcomes with edoxaban versus warfarin according to age. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Eri Toda, Giugliano, Robert P., Ruff, Christian T., Koretsune, Yukihiro, Yamashita, Takeshi, Kiss, Robert Gabor, Nordio, Francesco, Murphy, Sabina A., Kimura, Tetsuya, Jin, James, Lanz, Hans, Mercuri, Michele, Braunwald, Eugene, Antman, Elliott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889207/
https://www.ncbi.nlm.nih.gov/pubmed/27207971
http://dx.doi.org/10.1161/JAHA.116.003432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889207/
https://www.ncbi.nlm.nih.gov/pubmed/27207971
http://dx.doi.org/10.1161/JAHA.116.003432

Ejemplares similares